Chlorethanamine

Chlorethanamine

SCHEMBL508042

CC(N)Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Chlorethanamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 434 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115505003-B Preparation method of ifosfamide and preparation method of ifosfamide for injection 海南锦瑞制药有限公司 2025-03-25 CN claimed
CN-115873266-B Preparation method and application of polypeptide grafted sodium alginate-chitosan gel 融致丰生制药有限公司 2025-01-14 CN claimed
CN-119185640-A MOFs-based composite hydrogel antibacterial dressing and preparation method thereof 扬州工业职业技术学院 2024-12-27 CN claimed
CN-118307897-A Low-temperature-resistant composite material for refrigerator refrigerating chamber 安徽冠泓塑业有限公司 2024-07-09 CN claimed
CN-114539307-B CO (carbon monoxide) 2 Trapping material, synthesis method thereof and carbon trapping process 苏州仕净科技股份有限公司 2024-02-13 CN claimed
CN-116969903-B Efficient preparation method of thiazate 昊维联众生物医药技术(天津)有限公司 2023-12-12 CN claimed
CN-116969903-A Efficient preparation method of thiazate 昊维联众生物医药技术(天津)有限公司 2023-10-31 CN claimed
CN-115340814-B Preparation and application of cationic polyurethane antibacterial coating 苏州邦得纳米涂层科技有限公司 2023-08-01 CN claimed
CN-115873266-A Preparation method and application of polypeptide grafted sodium alginate-chitosan gel 融致丰生制药有限公司 2023-03-31 CN claimed
CN-115591751-A Processing technology of gradient color film 东莞瑞彩光学薄膜有限公司(CN) 2023-01-13 CN claimed
EP-1059915-B1 CROSS-LINKED HIGH AMYLOSE STARCH HAVING FUNCTIONAL GROUPS AS A MATRIX FOR THE SLOW RELEASE OF PHARMACEUTICAL AGENTS LENAERTS VINCENT (CA) 2004-09-29 EP claimed
EP-0844891-A4 HYPER COMB-BRANCHED POLYMER CONJUGATES DOW CHEMICAL CO (US) 2004-05-06 EP claimed
US-6419957-B1 CROSSLINKED WITH MONOCHLOROACETIC ACID OR CHLOROETHYLAMINE HYDROCHLORIDE LABOPHARM, INC. (CA) 2002-07-16 US claimed
CN-1298297-A Cross-linked high amylose starch with functional groups as a slow release matrix for pharmaceutical formulations VINCENT LENAERTS (CA) 2001-06-06 CN claimed
EP-1059915-A1 CROSS-LINKED HIGH AMYLOSE STARCH HAVING FUNCTIONAL GROUPS AS A MATRIX FOR THE SLOW RELEASE OF PHARMACEUTICAL AGENTS Lenaerts, Vincent (CA) 2000-12-20 EP claimed
WO-1999043305-A1 CROSS-LINKED HIGH AMYLOSE STARCH HAVING FUNCTIONAL GROUPS AS A MATRIX FOR THE SLOW RELEASE OF PHARMACEUTICAL AGENTS LENAERTS VINCENT (CA) 1999-09-02 WO claimed
EP-0844891-A1 HYPER COMB-BRANCHED POLYMER CONJUGATES DENDRITECH, INC. (US) 1998-06-03 EP claimed
WO-1997006833-A9 HYPER COMB-BRANCHED POLYMER CONJUGATES 1997-04-10 WO claimed
WO-1997006833-A1 HYPER COMB-BRANCHED POLYMER CONJUGATES DENDRITECH, INC. (US) 1997-02-27 WO claimed
EP-0408398-A1 Granular cysteamine hydrochloride and method for production thereof NIPPON SHOKUBAI CO., LTD. (JP) 1991-01-16 EP claimed